Barriers to receiving testosterone replacement therapy in the community during COVID-19 pandemic.

ABSTRACT:

Background

While the etiology for the upsurge in testosterone testing and prescriptions is likely multifactorial, increased direct-to-consumer marketing and the expansion of clinical care centers devoted to testosterone treatment likely play a role. Many of these centers require patients to report, in-person, on a regular basis for their injectable therapy and/or lab studies. The purpose of our study was to investigate barriers of care that patients receiving treatment for testosterone deficiency may be experiencing in the setting of COVID-19.

Methods

Our survey was posted on a closed Facebook support page for males currently receiving testosterone treatment and members of the group were invited to participate. The survey asked participants several questions related to how t

SUBMITTER: Troesch VL 

PROVIDER: S-EPMC8421835 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature